Key result
Higher Body Mass Index was associated with preserved-EF ischemic heart disease status compared to controls, with an adjusted relative risk ratio of 3.94 per 5 kg/m2 increase.
Why the study?
The study was conducted to compare BMI and LDL-C across database-defined reference controls, hypertension, and preserved-EF ischemic heart disease without assuming HFpEF.
Does higher BMI associate with preserved-EF ischemic heart disease status in adults?
Cross-Sectional (n=128)
No
Does higher BMI associate with preserved-EF ischemic heart disease status in adults?
BMI differed more consistently across clinical groups than contemporaneous LDL-C, highlighting the confounding effect of statin therapy on cross-sectional lipid measurements.
Answers are grounded in this paper and cite their sources.
Higher BMI may signal preserved-EF ischemic risk beyond statin-adjusted LDL-C; leaves open causal inference and prospective validation.
Background/Objectives: We compared BMI and LDL-C across database-defined reference controls, hypertension, and preserved-EF ischemic heart disease without assuming HFpEF. Methods: This single-center retrospective cross-sectional study included 128 adults (20 controls, 46 with hypertension, and 62 in the preserved-EF ischemic group). Analyses included nonparametric tests, multinomial regression, clinical-group models with and without statin adjustment, and a post hoc common-age sensitivity analysis. Results: Median BMI was 25.89, 28.25, and 29.00 kg/m2, respectively (p < 0.001); median LDL-C was 86.0, 109.5, and 100.0 mg/dL (p = 0.055), alongside statin use of 0%, 50.0%, and 87.1%. Per 5 kg/m2 higher BMI, the adjusted RRR for preserved-EF ischemic versus control status was 3.94 (95% CI 1.60–9.71; p = 0.003) and remained 3.48 (95% CI 1.35–8.97; p = 0.010) among participants aged 40–68 years. In clinical-group models, BMI estimates were similar without and with statin adjustment (OR 1.76 and 1.89); LDL-C was not independently associated with preserved-EF ischemic status. Conclusions: BMI differed more consistently across groups than treated, contemporaneous LDL-C. These associations are imprecise and describe group status; they do not establish causation, progression, prospective HF risk, or HFpEF.
No takes yet. Share an insight, caveat, or question.
Stoichescu-Hogea et al. (2026) conducted a cross-sectional in Hypertension and preserved-EF ischemic heart disease (n=128). Body Mass Index (BMI) vs. Controls was evaluated on Preserved-EF ischemic heart disease versus control status (RRR 3.94, 95% CI 1.60-9.71, p=0.003). Higher Body Mass Index was associated with preserved-EF ischemic heart disease status compared to controls, with an adjusted relative risk ratio of 3.94 per 5 kg/m2 increase.
Synapse has enriched 10 related papers. Consider them for comparative context: